Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on QT/QTc Interval
of a Single Dose of FYU-981, Compared with Placebo, Using Moxifloxacin as a Positive Control,
in Healthy Male and Female Volunteers.
Phase:
Phase 2
Details
Lead Sponsor:
Fuji Yakuhin Co., Ltd.
Treatments:
Dotinurad Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination